A Deep Dive into the SGN-70 Antibody This SGN-70 antibody represents a novel approach in cancer, specifically targeting CD22 expressed on various leukemias and lymphomas. Developed by the researchers, this antibody functions as an ADCC mechanism inducer, triggering the body's destruction of cancer cells. Studies have revealed early benefit in resi